Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0552
D

Failure to Obtain Consent for Psychotropic Medication Administration

Memphis, Tennessee Survey Completed on 05-13-2025

Penalty

Fine: $39,293
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to obtain consent for the administration of psychotropic medications for two of five sampled residents reviewed for unnecessary medications. Facility policy requires that residents, families, and/or representatives be involved in the medication management process, and that psychotropic medications are not administered unless clinically indicated and with proper documentation. However, review of medical records and interviews revealed that consent was not obtained for the use of antipsychotic and antidepressant medications for two residents. One resident with severe cognitive impairment and diagnoses including psychosis and dementia was prescribed and administered Seroquel and Zoloft. Medical records showed ongoing use of these medications, but there was no documentation of consent from the resident's family or representative. In a telephone interview, the resident's family member stated they were unaware of the medications being administered. Another resident, who was cognitively intact and diagnosed with bipolar disorder, depression, and anxiety, received multiple psychotropic medications including Ativan, Risperidone, and Trazodone. Medical record review confirmed frequent administration of these medications, but again, no consent forms were found. Interviews with facility staff, including the Social Service Director and DON, confirmed that consents for psychotropic medications had not been obtained for these residents at the time of review.

An unhandled error has occurred. Reload 🗙